Trial Profile
A trial to assess the impact of palifermin on oral mucositis (OM) and its sequelae in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) who were conditioned with fractionated total body irradiation (FTBI) and etoposide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Palifermin (Primary)
- Indications Stomatitis
- Focus Therapeutic Use
- 02 Jun 2016 New trial record